Abstract
p 1⁄4 0.009), male sex (OR 1.83, p 6 (OR 1.64, p 1⁄4 0.002). These same factors were independently associated with risk of unfavorable pathology: size > 2.5 cm (OR 1.53, p1⁄40.006), male sex (OR 1.90, p 6 (OR 1.54, p 1⁄40.024) Tables 1 and 2 show the risk of RCC and unfavorable pathology, respectively. CONCLUSIONS: The treatment of cT1a renal masses must include a discussion of the likely pathologic outcome for each patient. In this multi-institutional cohort, imaging tumor size >2.5 cm, male sex and nephrometry score > 6 were predictors of RCC and adverse pathology following PN. These factors may assist in risk stratification and selective renal mass biopsy prior to decisionmaking. Further studies are necessary to validate these findings.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have